RxDoctor Payments Data

Stewart Kamen, DPM

Foot Surgery · Bronxville, NYNPI 1043239452

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Stryker at 37.2% of the total. Reporting peaked in 2019 at $962 and has fallen 74.4% since, to $246 in 2025.

$2,909in general payments, 2019–2025

Across 40 payments — averaging $72.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Kerecis Limited$566
  • Cardiovascular Systems Inc.$200
  • Osiris Therapeutics Inc.$174
  • Lifenet Health$140
  • Treace Medical Concepts, Inc.$135
  • plus $614 from 8 others

What the payments were for

  • Food & beverage$2,81397%
  • Gifts$953%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,909 in reported general payments places this provider in the 80th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$87,004
Medicare patients
355
Services billed
858

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine19$536
Ciclopirox12$496
Ammonium Lactate17$395
Diclofenac Sodium ErDiclofenac Sodium17$249
Terbinafine Hcl11$150
Meloxicam23$75
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$72

Paid to pharmacies, not to this prescriber.

Other foot surgery in Bronxville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →